Militia Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$6.59M |
| 2 |
Inter&Co
INTR
|
+$6.05M |
| 3 |
RELX
RELX
|
+$5.42M |
| 4 |
EPAM Systems
EPAM
|
+$5.28M |
| 5 |
Moderna
MRNA
|
+$4.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$9.79M |
| 2 |
STMicroelectronics
STM
|
+$4.69M |
| 3 |
Factset
FDS
|
+$3.61M |
| 4 |
MRX
Marex Group Limited Ordinary Shares
MRX
|
+$3.61M |
| 5 |
Adobe
ADBE
|
+$3.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 3.39% |
| 2 | Healthcare | 3.38% |
| 3 | Industrials | 2.15% |
| 4 | Technology | 1.8% |
| 5 | Consumer Discretionary | 1.36% |
Similar funds
Militia Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Militia Capital Management held 392 positions worth $3.37B, up 241% from $989M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Militia Capital Management deployed $2.32B of net new capital in Q2 2026, opening 119 new positions and adding to 60 existing holdings. Its largest new stake was Nektar Therapeutics: 90,000 shares worth $6.28M.
By sector, the portfolio is most concentrated in Financials at 3.4% of assets, down from 8.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was STMicroelectronics, an estimated $4.69M trimmed.
- Militia Capital Management's largest Q2 2026 buy was Nektar Therapeutics: 90,000 shares worth $6.28M.
- Militia Capital Management added most to Moderna in Q2 2026, an estimated $4.43M increase.
- Militia Capital Management's biggest Q2 2026 reduction was STMicroelectronics, cutting an estimated $4.69M.
- Militia Capital Management fully exited iShares Bitcoin Trust in Q2 2026, selling an estimated $9.79M.
- Militia Capital Management's ten largest holdings make up 79% of its $3.37B portfolio in Q2 2026.
- Militia Capital Management opened 119 new positions and closed 114 in Q2 2026.
- Militia Capital Management's portfolio value rose 241% quarter-over-quarter to $3.37B.
Based on Militia Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.